Afatinib vs erlotinib in Chinese patients with advanced SCCof the lung- Video Abstract ID 161506

Video abstract of original research “ Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung” published in the open access journal OncoTargets and Therapy by Lu S, Li W, Zhou C, et al. Read the full paper here: https://www.dovepress.com/afatinib-vs-erlotinib-for-second-line-treatment-of-chinese-patients-wi-peer-reviewed-article-OTT